Maria C. Manara
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcoma.
Journal: Scientific reports
Published: February 24, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.
Journal: Cancer research
Published: November 19, 2025
CD99: A Key Regulator in Immune Response and Tumor Microenvironment.
Journal: Biomolecules
Published: February 28, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 29, 2025
Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.
Journal: Science translational medicine
Published: May 29, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape.
Journal: Journal of cell communication and signaling
Published: April 23, 2024
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma.
Journal: Cancers
Published: June 16, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Journal: Cancer immunology research
Published: May 26, 2023
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 09, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.
Journal: Clinical epigenetics
Published: September 28, 2022
Last Updated: 09/26/2026